Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination

被引:459
作者
Vedadi, Masoud
Niesen, Frank H.
Allali-Hassani, Abdellah
Fedorov, Oleg Y.
Finerty, Patrick J., Jr.
Wasney, Gregory A.
Yeung, Ron
Arrowsmith, Cheryl
Ball, Linda J.
Berglund, Helena
Hui, Raymond
Marsden, Brian D.
Nordlund, Par
Sundstrom, Michael
Weigelt, Johan
Edwards, Aled M.
机构
[1] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada
[2] Univ Oxford, Botnar Res Ctr, Struct Genom Consortium, Oxford OX3 7LD, England
[3] Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden
基金
英国惠康基金;
关键词
chemical biology; crystallography; human;
D O I
10.1073/pnas.0605224103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The 3D structures of human therapeutic targets are enabling for drug discovery. However, their purification and crystallization remain rate determining. In individual cases, ligands have been used to increase the success rate of protein purification and crystallization, but the broad applicability of this approach is unknown. We implemented two screening platforms, based on either fluorimetry or static light scattering, to measure the increase in protein thermal stability upon binding of a ligand without the need to monitor enzyme activity. In total, 221 different proteins from humans and human parasites were screened against one or both of two sorts of small-molecule libraries. The first library comprised different salts, pH conditions, and commonly found small molecules and was applicable to all proteins. The second comprised compounds specific for protein families of particular interest (e.g., protein kinases). In 20 cases, including nine unique human protein kinases, a small molecule was identified that stabilized the proteins and promoted structure determination. The methods are cost-effective, can be implemented in any laboratory, promise to increase the success rates of purifying and crystallizing human proteins significantly, and identify new ligands for these proteins.
引用
收藏
页码:15835 / 15840
页数:6
相关论文
共 16 条
[1]  
ARAI K, 1981, J BIOL CHEM, V256, P5247
[2]   Hit and lead generation:: Beyond high-throughput screening [J].
Bleicher, KH ;
Böhm, HJ ;
Müller, K ;
Alanine, AI .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378
[3]   Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase [J].
Bullock, AN ;
Debreczeni, JÉ ;
Fedorov, OY ;
Nelson, A ;
Marsden, BD ;
Knapp, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7604-7614
[4]  
Christendat D, 2000, NAT STRUCT BIOL, V7, P903
[5]  
Dobrovetsky Elena, 2005, Journal of Structural and Functional Genomics, V6, P33, DOI 10.1007/s10969-005-1363-5
[6]   High-level production and optimization of monodispersity of 11β-hydroxysteroid dehydrogenase type 1 [J].
Elleby, B ;
Svensson, S ;
Wu, XQ ;
Stefansson, K ;
Nilsson, J ;
Hallén, D ;
Oppermann, U ;
Abrahmsén, L .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1700 (02) :199-207
[7]   A simple method for improving protein solubility and long-term stability [J].
Golovanov, AP ;
Hautbergue, GM ;
Wilson, SA ;
Lian, LY .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (29) :8933-8939
[8]   Kinetics of protein aggregation. Quantitative estimation of the chaperone-like activity in test-systems based on suppression of protein aggregation [J].
Kurganov, BI .
BIOCHEMISTRY-MOSCOW, 2002, 67 (04) :409-422
[9]   Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery [J].
Lo, MC ;
Aulabaugh, A ;
Jin, GX ;
Cowling, R ;
Bard, J ;
Malamas, M ;
Ellestad, G .
ANALYTICAL BIOCHEMISTRY, 2004, 332 (01) :153-159
[10]   Thermodynamic stability of carbonic anhydrase: Measurements of binding affinity and stoichiometry using ThermoFluor [J].
Matulis, D ;
Kranz, JK ;
Salemme, FR ;
Todd, MJ .
BIOCHEMISTRY, 2005, 44 (13) :5258-5266